Compound Summary
Myxothiazol
Compound Information
Myxothiazol
Compound Name: | Myxothiazol |
Compound CID: | 10972974 |
Synonyms: | Myxothiazol 76706-55-3 Myxothiazol A UNII-6VY98BQ7NB 6VY98BQ7NB More... |
Iupac Name: | (2E,4R,5S,6E)-3,5-dimethoxy-4-methyl-7-[2-[2-[(2S,3E,5E)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl]-1,3-thiazol-4-yl]hepta-2,6-dienamide |
InChI: | InChI=1S/C25H33N3O3S2/c1-16(2)9-7-8-10-17(3)24-28-20(15-33-24)25-27-19(14-32-25)11-12-21(30-5)18(4)22(31-6)13-23(26)29/h7-18,21H,1-6H3,(H2,26,29)/b9-7+,10-8+,12-11+,22-13+/t17-,18+,21-/m0/s1 |
InChIKey: | XKTFQMCPGMTBMD-FYHMSGCOSA-N |
Canonical Smiles: | CC(C)C=CC=CC(C)C1=NC(=CS1)C2=NC(=CS2)C=CC(C(C)C(=CC(=O)N)OC)OC |
Isomeric Smiles: | C[C@@H](/C=C/C=C/C(C)C)C1=NC(=CS1)C2=NC(=CS2)/C=C/[C@@H]([C@@H](C)/C(=C\C(=O)N)/OC)OC |
Molecular Weight: | 487.7 |
Molecular Formula: | C25H33N3O3S2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Myxothiazol
Molecular Weight: | 487.7 |
Molecular Formula: | C25H33N3O3S2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 12 |
Heavy Atom Count: | 33 |
Complexity: | 738 |
Synonyms
Myxothiazol
| Myxothiazol | Myxothiazol |
|---|---|
Myxothiazol |
76706-55-3 |
Myxothiazol A |
UNII-6VY98BQ7NB |
6VY98BQ7NB |
(2Z,6E)-7-{2-(2E,4E)-1,6-DIMETHYLHEPTA-2,4-DIENYL-2,4-BI-1,3-THIAZOL-4-YL}-3,5-DIMETHOXY-4-METHYLHEPTA-2,6-DIENAMIDE |
(2E,4R,5S,6E)-3,5-dimethoxy-4-methyl-7-2-2-(2S,3E,5E)-7-methylocta-3,5-dien-2-yl-1,3-thiazol-4-yl-1,3-thiazol-4-ylhepta-2,6-dienamide |
(2Z,4R,5S,6E)-3,5-dimethoxy-4-methyl-7-2-2-(2S,3E,5E)-7-methylocta-3,5-dien-2-yl-1,3-thiazol-4-yl-1,3-thiazol-4-ylhepta-2,6-dienamide |
1sqp |
SCHEMBL447904 |
CHEMBL454568 |
ZINC12504487 |
DB04741 |
2,6-Heptadienamide, 7-(2-(1,6-dimethyl-2,4-heptadienyl)(2,4-bithiazol)-4-yl)-3,5-dimethoxy-4-methyl- |
HY-112177 |
CS-0043613 |
Q27463616 |
(2E,4R,5S,6E)-7-{2-(1S,2E,4E)-1,6-dimethylhepta-2,4-dien-1-yl-2,4-bi-1,3-thiazol-4-yl}-3,5-dimethoxy-4-methylhepta-2,6-dienamide" |
(2Z,6E)-7-{2-(2E,4E)-1,6-DIMETHYLHEPTA-2,4-DIENYL-2,4-BI-1,3-THIAZOL-4-YL}-3,5-DIMETHOXY-4-METHYLHEPTA-2,6-DIENAMID" |
2,6-Heptadienamide, 7-(2-((1S,2E,4E)-1,6-dimethyl-2,4-heptadienyl)(2,4-bithiazol)-4-yl)-3,5-dimethoxy-4-methyl-, (2E,4R,5S,6E)-" |
Experimental Data
Myxothiazol
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 10.000000000000000 | umol/L | 13.300000000000000 | 17.600000000000000 | 0.320000000000000 | 28.000000000000000 | 36.000000000000000 | 0.290000000000000 | S | N2 | 18221415 | Active |
Experimental Data Visualization
Myxothiazol
Statistics Data
Myxothiazol
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0.320000000000000 | 0.290000000000000 | 1 | 1 |
Statistics Data Visualization
Myxothiazol
